Antibodies directed against an LDL receptor

Details for Australian Patent Application No. 2006274752 (hide)

International Classifications

Event Publications

3 April 2008 PCT application entered the National Phase

PCT publication WO2007/014992 Priority application(s): WO2007/014992

5 June 2008 Alteration of Name

The name of the applicant has been altered to Laboratoire Francais Du Fractionnement Et Des Biotechnologies

25 September 2008 Section 223 Application Received

Laboratoire Francais Du Fractionnement Et Des Biotechnologies An application to extend the time from 07 Feb 2007 to 07 Mar 2008 in which to comply with Section 6(c) has been filed . Address for service in Australia - Griffith Hack Level 3 509 St Kilda Road Melbourne VIC 3004

13 November 2008 Section 223 Application Allowed

Laboratoire Francais Du Fractionnement Et Des Biotechnologies The time in which to comply with Section 6(c) has been extended to 07 Mar 2008. Address for service in Australia - Griffith Hack Level 3 509 St Kilda Road Melbourne VIC 3004 Extensions of Time, Section 223

21 May 2009 Assignment before Grant

Laboratoire Francais Du Fractionnement Et Des Biotechnologies The application has been assigned to LFB Biotechnologies

17 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.